Truveta’s groundbreaking study analyzing real-world use of GLP-1 receptor agonist (GLP-1 RA) therapies in adults with overweight or obesity has published in JAMA Network Open, offering critical ...
ICON plc, a clinical research organization, expanded its portfolio of artificial intelligence (AI) tools that aim to deliver efficiencies across the clinical trial process, including study startup, ...
Guru is dedicated to improving workplace technology capabilities. The creation of Guru is an extension of a larger effort to efficiently address fundamental pain points of contemporary companies, ...